🇺🇸 FDA
Patent

US 8329744

Methods of preventing the serotonin syndrome and compositions for use thereof

granted A61KA61K31/34A61K45/06

Quick answer

US patent 8329744 (Methods of preventing the serotonin syndrome and compositions for use thereof) held by Relmada Therapeutics, Inc. expires Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Relmada Therapeutics, Inc.
Grant date
Tue Dec 11 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 06 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/34, A61K45/06